INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 58 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $182,000 | – | 24,800 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Devon Park Associates, LLC | 3,243,709 | $30,491,000 | 15.27% |
RHO CAPITAL PARTNERS INC | 2,870,584 | $26,983,000 | 8.96% |
Private Capital Advisors, Inc. | 293,000 | $2,754,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 295,000 | $2,773,000 | 0.35% |
Meditor Group Ltd | 51,111 | $480,000 | 0.25% |
EverPoint Asset Management, LLC | 825,000 | $7,755,000 | 0.20% |
Graticule Asia Macro Advisors LLC | 148,000 | $1,392,000 | 0.16% |
EAM Investors, LLC | 99,428 | $935,000 | 0.15% |
PURA VIDA INVESTMENTS, LLC | 26,800 | $252,000 | 0.14% |
Tekla Capital Management LLC | 425,000 | $3,995,000 | 0.14% |